跳至主要内容
临床试验/EUCTR2004-003255-39-FI
EUCTR2004-003255-39-FI进行中(未招募)不适用

Treatment protocol for elderly patients with mantle cell lymphoma (MCL). A phase II study of the Finnish Lymphoma Group.

The Finnish Lymphoma group0 个研究点目标入组 30 人开始时间: 2004年12月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria
  • -Patients with histologically confirmed mantle cell lymphoma
  • -Advanced stage II-IV
  • -Previously untreated
  • -65 years and older, or 55-65 years if not eligible for high dose chemotherapy
  • -Written informed consent
  • -Adequate organ function
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years)
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria
  • -Severe somatic or psychiatric disease including cardiac, pulmonary, renal and CNS diseases, severe chronic infections, and active malignant diseases
  • -Poor compliance

研究者

发起方
The Finnish Lymphoma group

相似试验